NEW YORK, May 14, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Progyny's executives wi
Shares of Progyny Inc. were headed for a record selloff Friday after the fertility-services company said the Supreme Court of Alabama's February ruling regarding in vitro fertilization seemed to scare

Why Is Progyny (PGNY) Stock Down 27% Today?

08:53am, Friday, 10'th May 2024
Progyny (NASDAQ: PGNY ) stock is falling hard on Friday after the fertility and family-building benefits solutions company announced earnings results for its first quarter of 2024. The bad news for
Progyny, Inc. (NASDAQ:PGNY ) Q1 2024 Earnings Conference Call May 9, 2024 4:45 PM ET Company Participants James Hart – Investor Relations Pete Anevski – Chief Executive Officer Mark Livingston –
Early Sales Activity and New Partnerships Provide Strong Start to Selling Season, Affirming Continued Demand for Fertility and Family Building Solutions Early Sales Activity and New Partnerships Provi
NEW YORK, April 25, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, will report its financial results for the
The organizations will host an event with Canada's leading providers, employers, and fertility advocates to show support for the millions in need of family building care The organizations will host an
'Mad Money' host Jim Cramer shares his small-cap healthcare stock picks.
CNBC's Jim Cramer said he thinks it could be a good year for small cap stocks and shared his top picks.
The leading benefits solution and largest infertility advocacy non-profit will host a series of events aimed at raising awareness for the millions of individuals facing family building challenges The
NEW YORK, March 18, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny
Menopause is among the female health conditions with the highest unmet need and has 'enormous potential for innovative treatments,' according to McKinsey.
Progyny, Inc. (PGNY) is recommended as a buy due to its potential for continued growth and positive long-term outlook. The recent weak share price is attributed to expected weak performance in 1Q24, b
Wagering on mid-cap stocks can potentially unlock investment treasures typically overlooked in the bustling market. Nestled between the giants and the upstarts, these stocks, with market capitalizatio
NEW YORK, March 11, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women's health benefits solution, today announced that Pete Anevski, Progyny
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE